Stephen Basso Innoviva, Inc. (INVA) insider trading activity

Stephen Basso is Chief Financial Officer of Innoviva, Inc.. Currently has a direct ownership of 23,281 shares of INVA, which is worth approximately $475,630. The most recent transaction as insider was on Aug 20, 2025, when has been sold 237 shares (Common Stock) at a price of $19.95 per share, resulting in proceeds of $4,728. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K

1.01% 3M change

92.47% 12M change

Total Value Held $475,630

Stephen Basso Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 20 2025	SELL Payment of exercise price or tax liability	$4,728 $19.95 p/Share	237 Reduced 1.01%	23,281 Common Stock
May 20 2025	SELL Payment of exercise price or tax liability	$4,450 $18.78 p/Share	237 Reduced 1.0%	23,518 Common Stock
May 15 2025	BUY Grant, award, or other acquisition	-	1,353 Added 5.39%	23,755 Common Stock
Feb 24 2025	BUY Grant, award, or other acquisition	$191,087 $18.08 p/Share	10,569 Added 32.06%	22,402 Common Stock
Feb 20 2025	SELL Payment of exercise price or tax liability	$19,985 $18.07 p/Share	1,106 Reduced 8.55%	11,833 Common Stock
Nov 15 2024	BUY Grant, award, or other acquisition	-	843 Added 6.12%	12,939 Common Stock
Mar 05 2024	BUY Grant, award, or other acquisition	$179,988 $14.88 p/Share	12,096 Added 50.0%	12,096 Common Stock

Also insider at

INZY

Inozyme Pharma, Inc. Healthcare

SVP Finance (PFO)

Stephen Basso

Chief Financial Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INVA shares.

Notify only if

Value

Insider Trading

Get notified when an Innoviva, Inc. insider buys or sells INVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Innoviva, Inc.

Track Activities on INVA

Account